The above diagram shows the color scheme of the layout in the main result page. The parent entities and officers are those entities, including individual and legal persons, have significant controls over the company in focus. The offspring entities and appointments are those entities that the company in focus can influence on.
Clicking the links on parent entities or officers, and offspring entities or managed companies will put them in focus and show upstream or downstream connections. In general, ascendant entities can be found by moving toward upstream, and descendant entities are by toward downstream. In this way, progenitor entities such as grandparent companies (parents of parent), sibling companies (children of parent), partner companies (parents of child), and progeny entities such as grandchild companies (children of child) can be found easily.
Parent entities and officers
Active
6
- 1
Kanji, Hussein
Born in October 1976Individual (26 offsprings)Officer
2021-09-15 ~ nowOF - Director → CIF 0 - 2
Macfarlane, James Oliver
Born in May 1988Individual (8 offsprings)Officer 2021-03-17 ~ nowOF - Director → CIF 0 - 3
Blight, Joshua Miles, Dr
Born in June 1991Individual (1 offspring)Officer 2019-10-30 ~ nowOF - Director → CIF 0 - 4
Walton, Kevin John Davlin
Born in February 1988Individual (1 offspring)Officer 2025-09-23 ~ nowOF - Director → CIF 0 - 5
Kemlo, Philip James Gordon
Born in October 1990Individual (1 offspring)Officer 2019-10-30 ~ nowOF - Director → CIF 0 - 6NW BROWN DIRECTORS NOMINEES LTD - 2007-11-21GEIF NOMINEES LIMITED - 2006-04-18
45, Whitfield Street, London, EnglandActive Corporate (2 parents, 42 offsprings)Officer 2024-01-05 ~ nowOF - Director → CIF 0
Ceased
4
- 1
Palomaki, Parsi Pirkka
Partner born in April 1970IndividualOfficer 2021-03-17 ~ 2021-09-15OF - Director → CIF 0 - 2
Cruz Gomes, Ariane Karla, Dr
Company Director born in February 1991IndividualOfficer 2019-10-30 ~ 2025-09-30OF - Director → CIF 0Dr Ariane Karla Cruz Gomes
Born in February 1991IndividualPerson with significant control 2019-10-30 ~ 2021-03-17PE - Right to appoint or remove directors → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0 - 3
Dr Joshua Miles Blight
Born in June 1991Individual (1 offspring)Person with significant control 2019-10-30 ~ 2021-03-17PE - Right to appoint or remove directors → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0 - 4
Ms Philip James Gordon Kemlo
Born in October 1990Individual (1 offspring)Person with significant control 2019-10-30 ~ 2021-03-17PE - Right to appoint or remove directors → CIF 0PE - Ownership of shares – More than 25% but not more than 50% → CIF 0PE - Ownership of voting rights - More than 25% but not more than 50% → CIF 0
Company in focus
BASEIMMUNE LTD
Standard Industrial Classification
72110 - Research And Experimental Development On Biotechnology
Brief company account
Average Number of Employees
172023-11-01 ~ 2024-10-31
112022-11-01 ~ 2023-10-31
Property, Plant & Equipment
194,261 GBP2024-10-31
61,434 GBP2023-10-31
Debtors
Current
830,860 GBP2024-10-31
610,489 GBP2023-10-31
Cash at bank and in hand
8,664,566 GBP2024-10-31
1,756,936 GBP2023-10-31
Current Assets
9,495,426 GBP2024-10-31
2,367,425 GBP2023-10-31
Creditors
Current, Amounts falling due within one year
-65,684 GBP2024-10-31
-407,971 GBP2023-10-31
Net Current Assets/Liabilities
9,429,742 GBP2024-10-31
1,959,454 GBP2023-10-31
Net Assets/Liabilities
9,624,003 GBP2024-10-31
2,020,888 GBP2023-10-31
Equity
Called up share capital
8 GBP2024-10-31
6 GBP2023-10-31
Share premium
13,346,837 GBP2024-10-31
4,150,971 GBP2023-10-31
Retained earnings (accumulated losses)
-3,722,842 GBP2024-10-31
-2,130,089 GBP2023-10-31
Equity
9,624,003 GBP2024-10-31
2,020,888 GBP2023-10-31
Property, Plant & Equipment - Gross Cost
Plant and equipment
199,495 GBP2024-10-31
36,936 GBP2023-10-31
Office equipment
6,603 GBP2024-10-31
4,865 GBP2023-10-31
Computers
62,958 GBP2024-10-31
17,677 GBP2023-10-31
Property, Plant & Equipment - Gross Cost
312,306 GBP2024-10-31
102,728 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
Plant and equipment
12,402 GBP2023-10-31
Office equipment
1,961 GBP2023-10-31
Computers
8,856 GBP2023-10-31
Property, Plant & Equipment - Accumulated Depreciation (Not Including Impairment)
41,294 GBP2023-10-31
Property, Plant & Equipment - Increase From Depreciation Charge for Year
Office equipment, Owned/Freehold
2,124 GBP2023-11-01 ~ 2024-10-31
Owned/Freehold
76,751 GBP2023-11-01 ~ 2024-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
Plant and equipment
55,152 GBP2024-10-31
Office equipment
4,085 GBP2024-10-31
Computers
26,316 GBP2024-10-31
Property, Plant & Equipment - Accumulated Depreciation & Impairment
118,045 GBP2024-10-31
Property, Plant & Equipment
Plant and equipment
144,343 GBP2024-10-31
24,534 GBP2023-10-31
Office equipment
2,518 GBP2024-10-31
2,904 GBP2023-10-31
Computers
36,642 GBP2024-10-31
8,821 GBP2023-10-31
Other Debtors
Current
717,261 GBP2024-10-31
599,542 GBP2023-10-31
Prepayments/Accrued Income
Current
113,599 GBP2024-10-31
10,947 GBP2023-10-31
Bank Overdrafts
Current
6,261 GBP2024-10-31
Other Remaining Borrowings
Current
306,667 GBP2023-10-31
Trade Creditors/Trade Payables
Current
33,676 GBP2024-10-31
75,213 GBP2023-10-31
Other Creditors
Current
6,549 GBP2024-10-31
3,241 GBP2023-10-31
Accrued Liabilities/Deferred Income
Current
19,198 GBP2024-10-31
22,850 GBP2023-10-31
Creditors
Current
65,684 GBP2024-10-31
407,971 GBP2023-10-31
Number of Shares Issued (Fully Paid)
Class 1 ordinary share
301,408 shares2024-10-31
301,408 shares2023-10-31
Par Value of Share
Class 1 ordinary share
0.000012023-11-01 ~ 2024-10-31
Number of Shares Issued (Fully Paid)
Class 2 ordinary share
157,499 shares2024-10-31
157,499 shares2023-10-31
Par Value of Share
Class 2 ordinary share
0.000012023-11-01 ~ 2024-10-31
Number of Shares Issued (Fully Paid)
Class 3 ordinary share
99,099 shares2024-10-31
99,099 shares2023-10-31
Par Value of Share
Class 3 ordinary share
0.000012023-11-01 ~ 2024-10-31
Number of Shares Issued (Fully Paid)
Class 4 ordinary share
185,672 shares2024-10-31
Par Value of Share
Class 4 ordinary share
0.000012023-11-01 ~ 2024-10-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
Amounts falling due within one year
52,004 GBP2023-10-31
Future Minimum Lease Payments Under Non-cancellable Operating Leases
52,004 GBP2023-10-31
- Registered number 12289125
BASEIMMUNE LTD
InfoThe London Bioscience Innovation Centre, Royal College Street, London NW1 0NHPRIVATE LIMITED COMPANY incorporated on 2019-10-30 (6 years 2 months). The company status is Active.The last date of confirmation statement was made at 2024-10-29CIF 0
Offspring entities and appointments
Active
0
- Not found in our database.
The content of this website is protected by AgonGuard.
© 2022- Polylogarithmic Technology Ltd (Registered in England and Wales No. 14256313). All rights reserved.
Contains public sector information retrieved at 12 November 2025 and
licensed under the Open Government Licence v3.0.